Cargando…
MASCoD—Multidimensional Assessment of Subjective Cognitive Decline
Subjective cognitive decline (SCD) is a subclinical cognitive impairment that is complained by the individual without being objectively supported at clinical, diagnostic, and neuropsychological levels. It can negatively impact on patient’s frailty and quality of life, as well as on the caregiver’s b...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748696/ https://www.ncbi.nlm.nih.gov/pubmed/36533024 http://dx.doi.org/10.3389/fpsyg.2022.921062 |
_version_ | 1784849879592337408 |
---|---|
author | Maffoni, Marina Pierobon, Antonia Fundarò, Cira |
author_facet | Maffoni, Marina Pierobon, Antonia Fundarò, Cira |
author_sort | Maffoni, Marina |
collection | PubMed |
description | Subjective cognitive decline (SCD) is a subclinical cognitive impairment that is complained by the individual without being objectively supported at clinical, diagnostic, and neuropsychological levels. It can negatively impact on patient’s frailty and quality of life, as well as on the caregiver’s burden. Moreover, it can be prodromal to Mild Cognitive Impairment or dementia. Although the clinical manifestations of SCD can differ along with several cognitive domains, to date there are only screening tools to investigate subjective memory complaints. Thus, the first aim of this paper is to propose a preliminary English and Italian version of a new screening tool called MASCoD (Multidimensional Assessment of Subjective Cognitive Decline); the second aim is to propose its preliminary adoption on a pilot sample. This schedule is a brief test derived from the review of the literature and the clinical experience provided by an experts panelist. From pilot tests, it seems promising as it can help the professional to make differential diagnosis and to predict the risk of developing severe cognitive impairment over time, developing a personalized care path. This screening tool is brief, easily embeddable in usual clinical assessment, and administrable by different professionals. Furthermore, following validation, it will allow to collect manifold cognitive manifestations of SCD, addressing the shortage of previous validated instruments globally assessing cognition affected by this condition. |
format | Online Article Text |
id | pubmed-9748696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97486962022-12-15 MASCoD—Multidimensional Assessment of Subjective Cognitive Decline Maffoni, Marina Pierobon, Antonia Fundarò, Cira Front Psychol Psychology Subjective cognitive decline (SCD) is a subclinical cognitive impairment that is complained by the individual without being objectively supported at clinical, diagnostic, and neuropsychological levels. It can negatively impact on patient’s frailty and quality of life, as well as on the caregiver’s burden. Moreover, it can be prodromal to Mild Cognitive Impairment or dementia. Although the clinical manifestations of SCD can differ along with several cognitive domains, to date there are only screening tools to investigate subjective memory complaints. Thus, the first aim of this paper is to propose a preliminary English and Italian version of a new screening tool called MASCoD (Multidimensional Assessment of Subjective Cognitive Decline); the second aim is to propose its preliminary adoption on a pilot sample. This schedule is a brief test derived from the review of the literature and the clinical experience provided by an experts panelist. From pilot tests, it seems promising as it can help the professional to make differential diagnosis and to predict the risk of developing severe cognitive impairment over time, developing a personalized care path. This screening tool is brief, easily embeddable in usual clinical assessment, and administrable by different professionals. Furthermore, following validation, it will allow to collect manifold cognitive manifestations of SCD, addressing the shortage of previous validated instruments globally assessing cognition affected by this condition. Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9748696/ /pubmed/36533024 http://dx.doi.org/10.3389/fpsyg.2022.921062 Text en Copyright © 2022 Maffoni, Pierobon and Fundarò. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychology Maffoni, Marina Pierobon, Antonia Fundarò, Cira MASCoD—Multidimensional Assessment of Subjective Cognitive Decline |
title | MASCoD—Multidimensional Assessment of Subjective Cognitive Decline |
title_full | MASCoD—Multidimensional Assessment of Subjective Cognitive Decline |
title_fullStr | MASCoD—Multidimensional Assessment of Subjective Cognitive Decline |
title_full_unstemmed | MASCoD—Multidimensional Assessment of Subjective Cognitive Decline |
title_short | MASCoD—Multidimensional Assessment of Subjective Cognitive Decline |
title_sort | mascod—multidimensional assessment of subjective cognitive decline |
topic | Psychology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748696/ https://www.ncbi.nlm.nih.gov/pubmed/36533024 http://dx.doi.org/10.3389/fpsyg.2022.921062 |
work_keys_str_mv | AT maffonimarina mascodmultidimensionalassessmentofsubjectivecognitivedecline AT pierobonantonia mascodmultidimensionalassessmentofsubjectivecognitivedecline AT fundarocira mascodmultidimensionalassessmentofsubjectivecognitivedecline |